Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neuronetics (STIM) FCF Margin (2017 - 2025)

Historic FCF Margin for Neuronetics (STIM) over the last 9 years, with Q3 2025 value amounting to 2.45%.

  • Neuronetics' FCF Margin rose 288700.0% to 2.45% in Q3 2025 from the same period last year, while for Sep 2025 it was 23.54%, marking a year-over-year increase of 74400.0%. This contributed to the annual value of 43.35% for FY2024, which is 48700.0% up from last year.
  • According to the latest figures from Q3 2025, Neuronetics' FCF Margin is 2.45%, which was up 288700.0% from 9.85% recorded in Q2 2025.
  • Neuronetics' FCF Margin's 5-year high stood at 6.17% during Q4 2023, with a 5-year trough of 99.4% in Q1 2023.
  • For the 5-year period, Neuronetics' FCF Margin averaged around 46.86%, with its median value being 43.84% (2022).
  • In the last 5 years, Neuronetics' FCF Margin surged by 558800bps in 2021 and then plummeted by -448000bps in 2024.
  • Neuronetics' FCF Margin (Quarter) stood at 35.56% in 2021, then skyrocketed by 44bps to 19.8% in 2022, then skyrocketed by 131bps to 6.17% in 2023, then plummeted by -726bps to 38.63% in 2024, then surged by 94bps to 2.45% in 2025.
  • Its FCF Margin stands at 2.45% for Q3 2025, versus 9.85% for Q2 2025 and 53.85% for Q1 2025.